University Children's hospital, Zürich
Welcome,         Profile    Billing    Logout  
 0 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Moeller, Alexander
cASPerCF, NCT04966234 / 2019-004511-31: A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus Infection

Recruiting
2/3
135
Europe, RoW
Posaconazole 100 MG [Noxafil], gastro-resistant tablets Noxafil® 100 mg, Posaconazole 40 MG/ML, 105 ml Noxafil® 40 mg/ml oral suspension
Bambino Gesù Hospital and Research Institute, University of Exeter, Radboud University, Consorzio per Valutazioni Biologiche e Farmacologiche
Cystic Fibrosis, Aspergillosis
04/23
11/23
NCT05074680: COVID-19 Antibody Responses In Cystic Fibrosis

Active, not recruiting
N/A
5
Europe
Blood sampling
Insel Gruppe AG, University Hospital Bern, European Cystic Fibrosis Society, Cystic Fibrosis Foundation
Cystic Fibrosis
12/23
07/25
SPAC, NCT03505216: Swiss Paediatric Airway Cohort

Recruiting
N/A
6000
Europe
University of Bern
Asthma, Wheezing, Cough, Exercise Induced Bronchospasm, Inspiratory Laryngeal Obstruction, Dysfunctional Breathing
06/25
06/30
SWISS-Pearl, NCT05427136: Early Pulmonary Dysfunction in Childhood Cancer Patients

Recruiting
N/A
140
Europe
Lung function measurements, Breath Analysis, Magnetic resonance imaging (MRI), Standardized interview to assess respiratory symptoms, Data collection for assessment of clinical parameters and cumulative doses to chemotherapy, radiation, surgery and HSCT, Collection of genetic samples
University Children's Hospital Basel
Pulmonary Dysfunction
06/51
06/51

Download Options